Today: 9 June 2026
SSE share price ends higher — what to watch before Monday’s London open
8 February 2026
1 min read

SSE share price ends higher — what to watch before Monday’s London open

London, Feb 8, 2026, 08:26 GMT — Market shut for the day.

  • SSE shares closed out Friday at 2,510 pence, up 1.21%.
  • Attention shifts to Ofgem’s looming transmission price-control deadline, with UK rate forecasts also in the spotlight.
  • SSE now sees full-year adjusted earnings per share landing between 144 and 152 pence, following its Q3 update.

SSE Plc finished Friday’s session up 1.21%, with shares settling at 2,510 pence on the London Stock Exchange.

The market’s weekend closure puts Monday in focus, since SSE counts as a major “rate-sensitive” utility in the UK. Investors are parsing how fast interest rates could come down and eyeing the next regulatory decisions—key for returns from SSE’s electricity networks, which sit at the heart of its investment strategy.

SSE (SSE.L) remains close to its 52-week peak in the FTSE 100. The company’s pouring money into renewables and network upgrades, tying its prospects to a pair of unpredictable factors: the regulator’s decisions on earnings, and whatever the weather turns up.

The stock moved from 2,465 pence up to 2,526 pence on Friday, after closing at 2,480 pence in the previous session. Market data showed roughly 6.6 million shares changed hands.

SSE this week projected adjusted earnings per share for 2025/26 at 144 to 152 pence, covering the year through March 2026. The company also highlighted a 64% surge in regulated networks investment to about £1.8 billion over the first nine months. Renewables output climbed 7% from a year ago, despite patchy weather.

SSE chief financial officer Barry O’Regan cited “accelerating investment” as the company’s priority under its £33 billion plan, according to a statement. He also referenced what he described as positive signals from government and regulators.

Hargreaves Lansdown equity analyst Aarin Chiekrie noted SSE’s latest profit outlook “landed in line with market expectations,” but flagged concerns that renewables, despite new capacity coming online, “are not always reliable” and remain “at the mercy of mother nature.” Source: Hargreaves Lansdown research

Friday brought a supportive backdrop. The FTSE 100 closed 0.6% higher, boosted by banks after the Bank of England hinted rates might come down should inflation keep falling. Utilities, often regarded as bond proxies, can benefit from lower yields—SSE outpaced the muted upticks seen across other UK defensive names.

Still, there’s no shortage of risks. SSE’s own trading statement called out its exposure to swings in weather, market dynamics, and how reliably its plants are running. And as for Ofgem’s proposed rules for the next round of transmission price controls — the mechanism that governs what network firms can spend and earn — SSE hasn’t decided yet whether it’s investable.

Mark your calendars: SSE’s “closed period” update lands April 2. The company has preliminary results for the year ending March 31, 2026, penciled in for May 28. Investors are eyeing March 3 as well—a key Ofgem transmission price control deadline. Source: SSE investor calendar

Stock Market Today

  • Aker BP Share Price Surges Amid Valuation Debate
    June 9, 2026, 11:54 AM EDT. Aker BP (OB:AKRBP) shares climbed to NOK347.7, marking a 55.05% total shareholder return over one year, outperforming peers in Norway's energy sector. Despite this momentum, the stock trades at an 8.6% premium over a fair value of NOK320.11, raising questions about valuation. The company aims to sustain production above 500,000 barrels per day past 2030, backed by projects like Yggdrasil and Johan Sverdrup, supporting revenue growth. Yet, potential risks include higher emissions costs and delays in key developments. Analysts offer cautious pricing, but a discounted cash flow (DCF) model from Simply Wall St suggests a much higher intrinsic value of NOK1,769.75, indicating significant undervaluation. Investors face a valuation divide between conservative targets and optimistic cash flow projections.

Latest articles

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

9 June 2026
Paranovus Entertainment shares soared 620% to $6.76 after filing to potentially sell up to $195 million in new stock—an amount far exceeding its $7.14 million market cap—raising major dilution risks for investors as the company eyes acquisitions but warns that future share sales could pressure the stock price or threaten operations.
Coupang Stock Gains as Privacy Ruling Approaches

Coupang Stock Gains as Privacy Ruling Approaches

9 June 2026
Coupang shares jumped 2% to $15.49, outperforming a falling market, as investors braced for South Korea’s privacy regulator to decide June 10 on possible sanctions over a data breach exposing 33.6 million records—a ruling that could trigger fines up to 3% of sales and impact the stock’s recovery.
AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

9 June 2026
AEP lifted its five-year capital plan to $78 billion after signing 7 gigawatts of new large-energy project agreements, with 90% of 63 gigawatts of expected incremental load by 2030 tied to data centers; shares recently traded at $127.27, up 26.9% over 52 weeks, with analysts’ mean price target at $142.76, as investors weigh execution risks and a new data-center rate structure.
Dow climbs in New York, but gains may stall

Dow climbs in New York, but gains may stall

9 June 2026
Dow jumps 154.87 points as tech rebounds and oil prices drop, with chipmakers like Intel and Broadcom up sharply; investors brace for Wednesday’s key inflation data and next week’s Fed meeting, which could sway rate expectations and market direction.
U.S. Stocks Hit Records This Week — Why the S&P 500 and Nasdaq Rally Survived the Oil Shock

Dow Up While Nasdaq Dips; AI Rally Meets Inflation Data

9 June 2026
Nuvalent soared after GSK agreed to buy the cancer drug developer for $10.6 billion in cash, valuing shares at $124—a 40% premium to Monday’s close—while investors awaited Wednesday’s key inflation data that could impact market direction and tech stock stability.
Fortescue share price set for Monday test as Cyclone Mitchell shuts Port Hedland
Previous Story

Fortescue share price set for Monday test as Cyclone Mitchell shuts Port Hedland

Windows 11 printer alert: Microsoft tightens the screws on legacy V3/V4 drivers in 2026
Next Story

Windows 11 printer alert: Microsoft tightens the screws on legacy V3/V4 drivers in 2026

Go toTop